Microvascular Resistance Reserve Predicts CAD Outcomes: HR 0.75 per Unit Increase

This meta-analysis evaluated the prognostic value of microvascular resistance reserve (MRR) in coronary artery disease (CAD) by analyzing five prospective studies with a total of 3,186 participants. The study aimed to determine the association between MRR and major adverse cardiovascular events (MACE). The primary endpoint was the hazard ratio (HR) for adverse cardiovascular outcomes per unit increase in MRR. Results indicated that a higher MRR significantly reduced the risk of adverse events (HR: 0.75; 95% CI: 0.64-0.88), with substantial heterogeneity (I² = 80.9%). When MRR was dichotomized, low MRR was associated with a more than two-fold increased risk for MACE (HR: 2.39; 95% CI: 1.66-3.43). Subgroup analyses revealed a stronger prognostic effect in patients with ST-segment elevation myocardial infarction (STEMI) compared to those with stable CAD (HR: 0.46 vs. 0.86; P for interaction < 0.0001). No specific safety or adverse events were reported in relation to MRR measurement. Clinically, these findings suggest that MRR is a robust, independent predictor of cardiovascular outcomes, particularly in acute coronary syndrome. A threshold of MRR ≥ 3 was identified as optimal for sensitivity and rule-out performance, indicating its potential utility in invasive physiological assessments for risk stratification.

What if a simple measure could help predict your heart health and potentially save your life? Heart disease is a major health issue, often complicated by the condition of the heart's tiny blood vessels, which can be hard to evaluate. A recent analysis looked at microvascular resistance reserve, a new way to assess how well these small blood vessels are functioning. The findings showed that higher levels of this measure are strongly associated with a lower risk of major heart problems, like heart attacks. Specifically, patients with low microvascular resistance reserve faced more than double the risk of serious heart events compared to those with higher levels. This is especially important for those experiencing acute coronary syndrome, a severe form of heart disease. While this research is promising, it’s important to note that more studies are needed to confirm these results and to see how best to use this information in everyday care. For now, understanding microvascular resistance could be a game-changer in how doctors evaluate and treat heart disease, leading to better outcomes for patients.